Chuanzi Yue and Marisa Miraldo argue in a recent Health Affairs Forefront piece that the answer is ‘yes’, but I am highly skeptical of their claim. Will IRA cause firms to allocate funds from marketing to R&D? One point they make is that the IRA’s Medicare Drug Price Negotiation program will reduce pharmaceutical expenses on…
The AI race heats up with a new kid on the block from China. How did it compare against a popular U.S. genAI engine on a simple healthcare industry question? The post DeepSeek v. ChatGPT: Why is healthcare so expensive in America? (Video) appeared first on MedCity News.
Through its partnership with Pelago, Lantern’s clients can access Pelago’s substance use disorder treatment through Lantern’s specialty care platform. The post Lantern Teams Up with Pelago to Expand Access to Substance Use Disorder Treatment appeared first on MedCity News.
Sequoia Project work group co-chairs discuss the state of granular data-sharing consent and some possible approaches to further progress
By EMILY JOHNSON Imagine you’re an executive at a large health system in a major metropolitan area. One morning, you wake up to a missed call and a voicemail from your PR leader. It’s urgent: one of your employees–who was also a patient and a member of the organization–has unexpectedly died by suicide. Their family…
Akero Therapeutics reported that at 96 weeks, 39% of patients who received the 50 mg dose of efruxifermin achieved improvement in fibrosis, or liver scarring, caused by the fatty liver disease MASH. This study previously failed to achieve statistically significant improvement at 36 weeks, but Akero executives say the latest results show that longer dosing…
Surgery centers are the next focus, President and CEO Martin Bonick told a recent industry conference. But that push is more likely to be about building than buying.
The transition to hybrid measures in 2024 has been more than just a regulatory requirement — it’s been a catalyst for meaningful change in how we approach quality reporting. Here are five critical insights that can help healthcare organizations comply with requirements and excel in their quality reporting journey. The post 5 Critical Lessons from…
HealthCare.gov insurers denied nearly one out of every five claims (19%) submitted for in-network services and an even larger share (37%) share of claims for out-of-network services in 2023, a new KFF analysis finds. The analysis examines the main source of publicly available data on claims denials and appeals for individual-market plans available through the…More
This brief analyzes federal transparency data released by the Centers for Medicare and Medicaid Services (CMS) on claims denials and appeals for non-group qualified health plans (QHPs) offered on HealthCare.gov in 2023. It finds that HealthCare.gov insurers denied nearly one out of every five claims (19%) submitted for in-network services. Information about the reasons for…